Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja E Marcus

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Nature Communications|August 4, 2025
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countriesFelix Teufel, Pia Roddewig, Maja E Marcus, et al.
Nature Medicine|January 26, 2024
Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countriesDorit Talia Stein, Marissa B Reitsma, Pascal Geldsetzer, et al.
Journal of the American Heart Association|July 2, 2021
Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 CountriesTabea K Kirschbaum, Michaela Theilmann, Nikkil Sudharsanan, et al.
Plos Medicine|March 4, 2021
Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey dataDavid Peiris, Arpita Ghosh, Jennifer Manne-Goehler, et al.
Bulletin of the World Health Organization|November 3, 2025
Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveysMubarak Ayodeji Sulola, Abla M Sibai, Albertino Damasceno, et al.
Journal of the American College of Cardiology|August 18, 2022
The Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income CountriesTabea K Kirschbaum, Nikkil Sudharsanan, Jennifer Manne-Goehler, et al.
The Lancet. Healthy Longevity|February 25, 2022
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adultsDavid Flood, Jacqueline A Seiglie, Matthew Dunn, et al.
JAMA|August 22, 2023
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income CountriesSang Gune K Yoo, Grace S Chung, Silver K Bahendeka, et al.
Diabetes Care|June 30, 2022
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level DataDavid Flood, Pascal Geldsetzer, Kokou Agoudavi, et al.
The Lancet. Global Health|September 21, 2023
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey dataNicholas Errol Rahim, David Flood, Maja E Marcus, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Communications|August 4, 2025
National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countriesFelix Teufel, Pia Roddewig, Maja E Marcus, et al.
Nature Medicine|January 26, 2024
Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countriesDorit Talia Stein, Marissa B Reitsma, Pascal Geldsetzer, et al.
Journal of the American Heart Association|July 2, 2021
Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 CountriesTabea K Kirschbaum, Michaela Theilmann, Nikkil Sudharsanan, et al.
Plos Medicine|March 4, 2021
Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey dataDavid Peiris, Arpita Ghosh, Jennifer Manne-Goehler, et al.
Bulletin of the World Health Organization|November 3, 2025
Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveysMubarak Ayodeji Sulola, Abla M Sibai, Albertino Damasceno, et al.
Journal of the American College of Cardiology|August 18, 2022
The Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income CountriesTabea K Kirschbaum, Nikkil Sudharsanan, Jennifer Manne-Goehler, et al.
The Lancet. Healthy Longevity|February 25, 2022
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adultsDavid Flood, Jacqueline A Seiglie, Matthew Dunn, et al.
JAMA|August 22, 2023
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income CountriesSang Gune K Yoo, Grace S Chung, Silver K Bahendeka, et al.
Diabetes Care|June 30, 2022
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level DataDavid Flood, Pascal Geldsetzer, Kokou Agoudavi, et al.
The Lancet. Global Health|September 21, 2023
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey dataNicholas Errol Rahim, David Flood, Maja E Marcus, et al.
Pageof 3